OT-0010

N/A

Report date: 2025/01/26 16:07:03
NME

Base Information

Drug NameOT-0010
Drug Alias NameOT-0010
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCD1d antigens modulators
TargetsCD1d antigens
Therapy Area/IndicationsSolid tumours
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesOrpheus Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesOrpheus Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsSolid tumours
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A